Yamana Gold Announces Preliminary Fourth Quarter and Full Year 2021 Operating Results, Exceeding Annual Production Guidance With Strong Cash Flow Generation and Standout Performances at Its Core Operations

NEXT STORY
Yamana Gold Provides Notice of Fourth Quarter and Full Year 2021 Results
PREV STORY
Global Health & Hygiene Market Trends 2022: Growing Wellness Tourism and Increasing Importance of Sustainability
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sanofi: EMA to review cemiplimab as a potential treatment for advanced cutaneous squamous cell carcinoma

  Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) EMA to review cemiplimab as a ...

author_avatar
NASDAQ Market News

Helsinn Group announces agreement to acquire worldwide rights to Valchlor/Ledaga, an approved and marketed alkylating agent for topical treatment of mycosis fungoides type cutaneous T-cell lymphoma

Helsinn Group announces agreement to acquire worldwide rights to Valchlor®/Ledaga® - an approved and marketed ...

author_avatar
NASDAQ Market News

InteloMed, Inc. to Exhibit Non-Invasive Monitoring System for Assessing Dialysis Tolerance at the American Society of Nephrology Annual Kidney Week

PITTSBURGH, PA--(Marketwired - Nov 16, 2016) - InteloMed, Inc., a leader in the development ...

author_avatar
NASDAQ Market News